Standard regimen works as well as newer drug for arthritis

06/12/2013 | HealthDay News

An older, less expensive regimen that combines methotrexate, sulfasalazine and hydroxychloroquine is as effective as the costlier combination of methotrexate and etanercept in treating rheumatoid arthritis patients who don't respond to methotrexate alone, a study found. U.S. researchers followed 353 patients and found no difference in improvements between the two groups. The study appeared online in the New England Journal of Medicine.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT